Rainer Kramer, Ph.D.

Chief Business Officer & Site Head Munich

Managing Director Immatics Biotechnologies GmbH

Rainer Kramer joined Immatics Biotechnologies GmbH in April 2012 from Signature Diagnostics AG where he was member of the Management Board and Chief Business Officer. He is responsible for Immatics’ business development, strategic alliance and early commercial activities.

During his career, he has delivered numerous strategic partnerships and license deals encompassing technology and product deals as well as equity transactions with an aggregate value of more than $5billion. Rainer Kramer has worked in research, business and corporate functions with increasing responsibilities at Amgen Inc., MorphoSys AG, Jerini AG, Shire PLC and Signature Diagnostics AG.

Further to his role at Immatics, Rainer Kramer is a non-executive director on the board of iOmx Therapeutics.

Rainer Kramer holds a diploma in molecular biology and a Ph.D. from the Max-Planck-Institute for Neurobiology, Martinsried, Germany.